Hemodynamic Effects of Combined Focal Cerebral Ischemia and Amyloid Protein Toxicity in a Rat Model: A Functional CT Study
暂无分享,去创建一个
[1] [Amyloid imaging]. , 2016, Nihon rinsho. Japanese journal of clinical medicine.
[2] E. Fainardi,et al. Improving Acute Stroke Management with Computed Tomography Perfusion: A Review of Imaging Basics and Applications , 2012, Translational Stroke Research.
[3] J P B O'Connor,et al. Dynamic contrast-enhanced imaging techniques: CT and MRI. , 2011, The British journal of radiology.
[4] P. Mcgeer,et al. Comparison of Vascular Perturbations in an Aβ-Injected Animal Model and in AD Brain , 2011, International journal of Alzheimer's disease.
[5] W. Brown,et al. Review: Cerebral microvascular pathology in ageing and neurodegeneration , 2011, Neuropathology and applied neurobiology.
[6] Sterling C. Johnson,et al. Effects of hypoperfusion in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[7] Debashis Mukhopadhyay,et al. AICD Overexpression in Neuro 2A Cells Regulates Expression of PTCH1 and TRPC5 , 2010, International journal of Alzheimer's disease.
[8] K. Miles,et al. Molecular imaging with dynamic contrast-enhanced computed tomography. , 2010, Clinical radiology.
[9] D. Holtzman,et al. Soluble amyloid-β, effect on cerebral arteriolar regulation and vascular cells , 2010, Molecular Neurodegeneration.
[10] B. Långström,et al. The use of PET in Alzheimer disease , 2010, Nature Reviews Neurology.
[11] S. de Santi,et al. Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. , 2010, Journal of Alzheimer's disease : JAD.
[12] J. Detre,et al. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[13] Norbert Schuff,et al. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging , 2009, Alzheimer's & Dementia.
[14] W. Klunk,et al. Update on amyloid imaging: From healthy aging to Alzheimer’s disease , 2009, Current neurology and neuroscience reports.
[15] H. Soininen,et al. Focal cerebral ischemia in rats alters APP processing and expression of Aβ peptide degrading enzymes in the thalamus , 2009, Neurobiology of Disease.
[16] James T Becker,et al. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.
[17] Yaakov Stern,et al. Contribution of vascular risk factors to the progression in Alzheimer disease. , 2009, Archives of neurology.
[18] L. White. Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study. , 2009, Journal of Alzheimer's disease : JAD.
[19] Rachel L. Mistur,et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[20] David C. Alsop,et al. Hippocampal hyperperfusion in Alzheimer's disease , 2008, NeuroImage.
[21] R. Pluta,et al. Brain ischemia and ischemic blood–brain barrier as etiological factors in sporadic Alzheimer’s disease , 2008, Neuropsychiatric Disease and Treatment.
[22] Michael Oliver Flüß,et al. Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging , 2008, NeuroImage.
[23] F. Leblhuber,et al. Value of cerebral blood flow quantification in the diagnosis of dementia , 2008, Nuclear medicine communications.
[24] J. C. Torre,et al. Pathophysiology of Neuronal Energy Crisis in Alzheimer’s Disease , 2008, Neurodegenerative Diseases.
[25] V. Hachinski,et al. Progressive Increase in Infarct Size, Neuroinflammation, and Cognitive Deficits in the Presence of High Levels of Amyloid , 2007, Stroke.
[26] Paul Maruff,et al. β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .
[27] Kwang-Soo Lee,et al. Clinical Significance of Silent Cerebral Infarctions in Patients With Alzheimer Disease , 2007, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.
[28] M. D'Andrea,et al. Aβ peptides can enter the brain through a defective blood–brain barrier and bind selectively to neurons , 2007, Brain Research.
[29] Simon A. Moss,et al. b -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease , 2007 .
[30] C. Ballard,et al. Quantification of Alzheimer pathology in ageing and dementia: age‐related accumulation of amyloid‐β(42) peptide in vascular dementia , 2006, Neuropathology and applied neurobiology.
[31] F. Donnerstag,et al. Correlative assessment of cerebral blood flow obtained with perfusion CT and positron emission tomography in symptomatic stenotic carotid disease , 2006, European Radiology.
[32] P. Wolf,et al. The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.
[33] J. Gore. Lifetime Risk for Stroke , 2006 .
[34] Hiroshi Matsuda,et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.
[35] Emmanuel L Barbier,et al. Comparative Overview of Brain Perfusion Imaging Techniques , 2005, Journal of neuroradiology. Journal de neuroradiologie.
[36] Sanjeet Pakrasi,et al. Emission tomography in dementia. , 2005, Nuclear medicine communications.
[37] N. Schuff,et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.
[38] V. Hachinski,et al. Interaction Between a Rat Model of Cerebral Ischemia and &bgr;-Amyloid Toxicity: Inflammatory Responses , 2005, Stroke.
[39] E. Larson,et al. Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study , 2004, Journal of the American Geriatrics Society.
[40] M. A. Bell,et al. Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities , 1981, Acta Neuropathologica.
[41] F. Crawford,et al. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. , 2003, Neurological research.
[42] A. Hofman,et al. Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.
[43] Tohru Shiga,et al. Quantitative cerebral blood flow measurement with dynamic perfusion CT using the vascular-pixel elimination method: comparison with H2(15)O positron emission tomography. , 2003, AJNR. American journal of neuroradiology.
[44] N. Patel,et al. Proinflammatory and Vasoactive Effects of Aβ in the Cerebrovasculature , 2002, Annals of the New York Academy of Sciences.
[45] D. Royall,et al. Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.
[46] R. Kauppinen,et al. β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Kauppinen,et al. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] T. Ohnishi,et al. Longitudinal Evaluation of Early Alzheimer's Disease Using Brain Perfusion Spect the Recruitment Was For , 2000 .
[49] M. Breteler. Vascular Involvement in Cognitive Decline and Dementia: Epidemiologic Evidence from the Rotterdam Study and the Rotterdam Scan Study , 2000, Annals of the New York Academy of Sciences.
[50] J. Shi,et al. Hypoperfusion induces overexpression of β-amyloid precursor protein mRNA in a focal ischemic rodent model , 2000, Brain Research.
[51] R. Craen,et al. Dynamic CT measurement of cerebral blood flow: a validation study. , 1999, AJNR. American journal of neuroradiology.
[52] Fiona Crawford,et al. Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo , 1998, Neuroscience Letters.
[53] R. Mohs,et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease , 1998, Neurology.
[54] C. Iadecola,et al. Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein , 1997, The Journal of Neuroscience.
[55] James A. Mortimer,et al. Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .
[56] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.
[57] G C Roman,et al. Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.
[58] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[59] T Nariai,et al. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. , 1995, AJNR. American journal of neuroradiology.